FTSE techMARK 100: Performance
8,084.67
-91.41 (-1.12%)Day high
8,214.10
8,214.10
Day low
8,046.03
8,046.03
FTSE techMARK 100 delayed by at least 15 minutes | Preferences
For prices and dates, hover over a value within the table.
| EPIC | Name | 1W | 1M | 3M | 6M
|
1Y | 2Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| % | |||||||||
| APTD | Aptitude Software Group plc | -1.85 | -11.67 | -27.89 | -30.26 | -26.64 | -30.94 | -43.47 | -70.06 |
| SGE | Sage Group plc | +5.13 | +1.95 | -18.44 | -22.15 | -30.37 | -31.43 | +10.50 | +37.02 |
| NCC | NCC Group plc | +3.83 | -6.57 | -11.16 | -19.00 | -15.68 | -3.71 | +16.83 | -55.36 |
| SN. | Smith & Nephew plc | +1.00 | -8.04 | -0.82 | -10.29 | +12.33 | +23.95 | +7.62 | -11.18 |
| QQ. | QinetiQ Group plc | +3.98 | -6.33 | +8.24 | -9.93 | +24.55 | +32.87 | +48.09 | +50.97 |
| XAR | Xaar | +5.00 | -2.53 | +13.24 | -6.48 | +21.58 | +6.94 | -44.40 | -20.89 |
| OXB | Oxford Biomedica plc | -2.61 | -13.18 | -14.50 | -6.04 | +104.01 | +185.71 | +28.88 | -41.18 |
| TRD | Triad Group plc | +0.00 | -3.33 | +11.54 | -4.92 | -10.77 | +19.83 | +110.91 | +123.08 |
| RSW | Renishaw plc | -5.13 | -14.17 | +1.55 | -2.70 | +42.49 | -17.13 | -11.94 | -44.28 |
| GNS | Genus plc | +2.01 | -11.81 | -0.20 | +0.79 | +36.41 | +45.81 | -11.62 | -48.37 |
| RM. | RM plc | +2.97 | -3.79 | -16.45 | +3.53 | -13.80 | +77.21 | +32.29 | -58.59 |
| BA. | BAE Systems plc | +9.36 | +2.14 | +30.50 | +11.12 | +45.75 | +71.98 | +132.95 | +348.47 |
| CCC | Computacenter plc | +6.95 | -3.51 | +5.41 | +12.34 | +24.72 | +14.25 | +43.97 | +26.35 |
| OXIG | Oxford Instruments plc | +0.60 | -5.48 | +21.65 | +27.68 | +42.69 | +22.55 | -0.20 | +24.69 |
| XPP | XP Power Limited | +1.92 | -7.96 | +42.28 | +41.49 | +67.15 | +20.45 | -37.49 | -73.22 |
Market chart provided by Digital Look. Market data provided by Netbuilder.
Performance figures are based on each share's previous closing price. Historical price data used to calculate performance figures provided by Thomson Reuters and Interactive Data Ltd. Past performance is not an indication of future performance.
